400 µg Brimonidine Tartrate Implant

DRUG3 trials

Sponsors

Allergan

Conditions

Macular DegenerationRetinitis PigmentosaVitrectomy

Phase 1

An Exploratory Study to Evaluate the Safety of Brimonidine Intravitreal Implant in Patients With Retinitis Pigmentosa

CompletedNCT00661479

AllerganRetinitis Pigmentosa

Start: 2008-07-31End: 2010-05-31Updated: 2013-04-24

Pharmacokinetics of the Brimonidine Tartrate Posterior Segment Delivery System in Patients Undergoing Pars Plana Vitrectomy

CompletedNCT01229410

AllerganVitrectomy

Start: 2010-12-31End: 2011-10-31Updated: 2013-08-05

Phase 2

Safety and Efficacy of Brimonidine Intravitreal Implant in Patients With Geographic Atrophy Due to Age-related Macular Degeneration (AMD)

CompletedNCT00658619

AllerganMacular Degeneration

Start: 2008-05-01End: 2011-04-08Updated: 2018-08-21